These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 16123136)
21. Experimental hemochromatosis due to MHC class I HFE deficiency: immune status and iron metabolism. Bahram S; Gilfillan S; Kühn LC; Moret R; Schulze JB; Lebeau A; Schümann K Proc Natl Acad Sci U S A; 1999 Nov; 96(23):13312-7. PubMed ID: 10557317 [TBL] [Abstract][Full Text] [Related]
22. The non-classical MHC class I molecule Qa-1(b) inhibits classical MHC class I-restricted cytotoxicity of cytotoxic T lymphocytes. Lohwasser S; Kubota A; Salcedo M; Lian RH; Takei F Int Immunol; 2001 Mar; 13(3):321-7. PubMed ID: 11222501 [TBL] [Abstract][Full Text] [Related]
23. HFE, the MHC and hemochromatosis: paradigm for an extended function for MHC class I. Cardoso CS; de Sousa M Tissue Antigens; 2003 Apr; 61(4):263-75. PubMed ID: 12753664 [TBL] [Abstract][Full Text] [Related]
24. Induction of TCR Vbeta-specific CD8+ CTLs by TCR Vbeta-derived peptides bound to HLA-E. Li J; Goldstein I; Glickman-Nir E; Jiang H; Chess L J Immunol; 2001 Oct; 167(7):3800-8. PubMed ID: 11564797 [TBL] [Abstract][Full Text] [Related]
25. H-2-restricted cytolytic T lymphocytes specific for HLA display T cell receptors of limited diversity. Casanova JL; Cerottini JC; Matthes M; Necker A; Gournier H; Barra C; Widmann C; MacDonald HR; Lemonnier F; Malissen B; Maryanski JL J Exp Med; 1992 Aug; 176(2):439-47. PubMed ID: 1380061 [TBL] [Abstract][Full Text] [Related]
26. Presentation of native TROP-2 tumor antigens to human cytotoxic T lymphocytes by engineered antigen-presenting cells. Mangino G; Grazia Capri M; Barnaba V; Alberti S Int J Cancer; 2002 Oct; 101(4):353-9. PubMed ID: 12209960 [TBL] [Abstract][Full Text] [Related]
27. TCR internalization induced by peptide/MHC ligands requires the transmembrane domains of alphabeta chains of TCR, but not the expression of CD8 and Thy-1 molecules. Lee MH; Min D; Sonn CH; Lee KN; Kim KE; Paik SG; Kim YS Mol Cells; 1999 Dec; 9(6):617-24. PubMed ID: 10672928 [TBL] [Abstract][Full Text] [Related]
28. Human CD8+ intraepithelial lymphocytes: a unique model to study the regulation of effector cytotoxic T lymphocytes in tissue. Jabri B; Ebert E Immunol Rev; 2007 Feb; 215():202-14. PubMed ID: 17291290 [TBL] [Abstract][Full Text] [Related]
29. Highly lytic CD8+, alpha beta T-cell receptor cytotoxic T cells with major histocompatibility complex (MHC) class I antigen-directed cytotoxicity in beta 2-microglobulin, MHC class I-deficient mice. Apasov S; Sitkovsky M Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2837-41. PubMed ID: 8464897 [TBL] [Abstract][Full Text] [Related]
30. [HFE, a MHC class Ib molecule that regulates iron metabolism]. Rohrlich PS; Kanellopoulos J; Lemonnier FA Med Sci (Paris); 2006 Jan; 22(1):24-6. PubMed ID: 16386215 [No Abstract] [Full Text] [Related]
31. TCR-independent killing of B cell malignancies by anti-third-party CTLs: the critical role of MHC-CD8 engagement. Lask A; Goichberg P; Cohen A; Goren-Arbel R; Milstein O; Aviner S; Feine I; Ophir E; Reich-Zeliger S; Hagin D; Klein T; Nagler A; Berrebi A; Reisner Y J Immunol; 2011 Aug; 187(4):2006-14. PubMed ID: 21753148 [TBL] [Abstract][Full Text] [Related]
32. Major histocompatibility complex class I-specific and -restricted killing of beta 2-microglobulin-deficient cells by CD8+ cytotoxic T lymphocytes. Glas R; Franksson L; Ohlén C; Höglund P; Koller B; Ljunggren HG; Kärre K Proc Natl Acad Sci U S A; 1992 Dec; 89(23):11381-5. PubMed ID: 1454824 [TBL] [Abstract][Full Text] [Related]
33. Alloreactive T cell recognition of MHC class I molecules: the T cell receptor interacts with limited regions of the MHC class I long alpha helices. Smith KD; Lutz CT J Immunol; 1997 Mar; 158(6):2805-12. PubMed ID: 9058816 [TBL] [Abstract][Full Text] [Related]
34. Cellular peptide composition governed by major histocompatibility complex class I molecules. Falk K; Rötzschke O; Rammensee HG Nature; 1990 Nov; 348(6298):248-51. PubMed ID: 2234092 [TBL] [Abstract][Full Text] [Related]
35. The Q7 alpha 3 domain alters T cell recognition of class I antigens. Aldrich CJ; Lowen LC; Mann D; Nishimura M; Hood L; Stroynowski I; Forman J J Immunol; 1991 May; 146(9):3082-90. PubMed ID: 1849941 [TBL] [Abstract][Full Text] [Related]
36. Recognition of the antigen-presenting molecule MR1 by a Vδ3 Rice MT; von Borstel A; Chevour P; Awad W; Howson LJ; Littler DR; Gherardin NA; Le Nours J; Giles EM; Berry R; Godfrey DI; Davey MS; Rossjohn J; Gully BS Proc Natl Acad Sci U S A; 2021 Dec; 118(49):. PubMed ID: 34845016 [TBL] [Abstract][Full Text] [Related]
37. Glu227-->Lys substitution in the acidic loop of major histocompatibility complex class I alpha 3 domain distinguishes low avidity CD8 coreceptor and avidity-enhanced CD8 accessory functions. Shen L; Potter TA; Kane KP J Exp Med; 1996 Nov; 184(5):1671-83. PubMed ID: 8920857 [TBL] [Abstract][Full Text] [Related]
38. The analysis of the natural killer-like activity of human cytolytic T lymphocytes revealed HLA-E as a novel target for TCR alpha/beta-mediated recognition. Pietra G; Romagnani C; Falco M; Vitale M; Castriconi R; Pende D; Millo E; Anfossi S; Biassoni R; Moretta L; Mingari MC Eur J Immunol; 2001 Dec; 31(12):3687-93. PubMed ID: 11745389 [TBL] [Abstract][Full Text] [Related]
39. Antigen recognition by H-2-restricted cytolytic T lymphocytes: inhibition of cytolysis by anti-CD8 monoclonal antibodies depends upon both concentration and primary sequence of peptide antigen. Maryanski JL; Pala P; Cerottini JC; MacDonald HR Eur J Immunol; 1988 Nov; 18(11):1863-6. PubMed ID: 3144458 [TBL] [Abstract][Full Text] [Related]
40. Single T cell receptor-mediated recognition of an identical HIV-derived peptide presented by multiple HLA class I molecules. Ueno T; Tomiyama H; Takiguchi M J Immunol; 2002 Nov; 169(9):4961-9. PubMed ID: 12391209 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]